Biomarkers in Alzheimer's disease and lewy body disorders with dementia

International Journal of Alzheimer's Disease

Volumn 2013, Issue , 2013, Pages

  Leyhe, Thomas ^a   Darreh Shori, Taher ^b   Laske, Christoph ^a,c,d   Mielke, Michelle M ^e   Maetzler, Walter ^c,d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ANGIOPOIETIN 1; BIOLOGICAL MARKER; BRAIN PROTEIN;

ALZHEIMER DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; HUMAN; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUALITY CONTROL;

EID: 84873360258     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2013/473181     Document Type: Editorial

References (0)